May 08, 2025

SGLT2 Inhibitors Lower Hyperkalemia Risk in Patients Taking RAASi 

Researchers found that starting SGLT2 inhibitors in older patients on RAAS inhibitors reduced the risk of hyperkalemia and helped more patients stay on RAAS therapy.

Conexiant

May 07, 2025

Aspirin Discontinuation Could Fail to Lower cSDH Recurrence

In a multicenter randomized trial, discontinuing aspirin for 12 days during subdural hematoma surgery did not lower recurrence rates or reduce bleeding compared to continuing the drug.

Conexiant

May 06, 2025

Anemia Linked to Hidden Heart Strain in RA

A new study found that 1 in 3 rheumatoid arthritis patients with normal heart function on standard tests had hidden heart strain detectable only through advanced imaging, with anemia emerging as the strongest predictor.

Conexiant

May 06, 2025

Weight Loss, Hypokalemia Reveal Pituitary Cushing’s Disease

A 75-year-old woman with severe weight loss and low potassium was diagnosed with pituitary Cushing’s disease, challenging assumptions about how the condition typically presents.

Conexiant

May 05, 2025

New Chikungunya Vaccine Shows Strong Response

A new single-dose chikungunya vaccine produced strong immune responses in nearly all adolescents and adults in a large clinical trial, with mild and short-lived side effects.

Conexiant

May 02, 2025

Personalizing Eating Disorder Care Advances, Study

A global research team reviewed current treatments for eating disorders and found that while personalization is seen as essential by patients and clinicians, most approaches still lack strong supporting evidence.

Conexiant

May 01, 2025

Phthalates Linked to Cardiovascular Mortality Globally

Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.

Conexiant

May 01, 2025

Stem Cell Therapies for Retinal Degenerations

Stem cell therapy harnesses the high regenerative potency of undifferentiated stem cells to replace diseased or dead cells. In recent years, stem cell therapy for retinal diseases has transitioned from preclinical investigation to early phase clinical trials with promising results. Both RPE replacement and photoreceptor transplantation strategies have shown the potential to preserve or restore visual function in conditions like AMD and RP, offering hope for conditions once considered irreversible.

Retinal Physician

May 01, 2025

Semaglutide Shows Potential in Liver Disease Trial

Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis.

Conexiant